Orbimed Advisors - KINNATE BIOPHARMA INC ownership

KINNATE BIOPHARMA INC's ticker is KNTE and the CUSIP is 49705R105. A total of 56 filers reported holding KINNATE BIOPHARMA INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 2.0%.

Quarter-by-quarter ownership
Orbimed Advisors ownership history of KINNATE BIOPHARMA INC
ValueSharesWeighting
Q3 2023$11,213,621
-53.8%
8,009,7290.0%0.24%
-45.9%
Q2 2023$24,269,479
-24.5%
8,009,729
+55.7%
0.44%
-30.3%
Q1 2023$32,147,681
+30.3%
5,143,629
+27.2%
0.63%
+33.7%
Q4 2022$24,666,137
-49.0%
4,043,6290.0%0.47%
-47.4%
Q3 2022$48,321,000
-5.2%
4,043,6290.0%0.90%
-2.9%
Q2 2022$50,990,000
+12.0%
4,043,6290.0%0.92%
+25.2%
Q1 2022$45,531,000
-33.2%
4,043,629
+5.1%
0.74%
-15.8%
Q4 2021$68,185,000
-23.0%
3,847,9290.0%0.88%
-9.9%
Q3 2021$88,579,000
-1.1%
3,847,9290.0%0.97%
+7.4%
Q2 2021$89,580,000
-25.3%
3,847,9290.0%0.91%
-19.2%
Q1 2021$119,901,000
-21.7%
3,847,9290.0%1.12%
-16.3%
Q4 2020$153,071,0003,847,9291.34%
Other shareholders
KINNATE BIOPHARMA INC shareholders Q4 2020
NameSharesValueWeighting ↓
Foresite Capital Management V, LLC 3,525,957$4,936,3407.88%
Foresite Capital Management IV, LLC 9,671,643$13,540,3007.52%
Vida Ventures Advisors, LLC 2,207,772$3,090,8814.78%
Lynx1 Capital Management LP 1,997,006$2,795,8081.85%
Nextech Invest Ltd. 2,329,480$3,261,2720.99%
Orbimed Advisors 8,009,729$11,213,6210.24%
Novo Holdings A/S 815,707$1,141,9900.08%
DAFNA Capital Management LLC 105,179$147,2510.05%
GSA CAPITAL PARTNERS LLP 374,291$5240.04%
Rock Springs Capital Management LP 405,811$568,1350.02%
View complete list of KINNATE BIOPHARMA INC shareholders